Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study.

Dan Beverly Fu, Xiao-Tang Kong, Tener Goodwin Veenema, Daniela A Bota, Binu Koirala
{"title":"Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study.","authors":"Dan Beverly Fu,&nbsp;Xiao-Tang Kong,&nbsp;Tener Goodwin Veenema,&nbsp;Daniela A Bota,&nbsp;Binu Koirala","doi":"10.6004/jadpro.2022.13.8.4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Clinical guidelines suggest that prophylactic antiepileptic drugs (AEDs) should be given to newly diagnosed seizure-naive brain tumor patients for up to 1 week after craniotomy. Yet, data suggest that prophylactic AEDs are used up to 12 months after surgery. A quality improvement project was implemented to improve adherence to evidence-based prophylactic AED guidelines.</p><p><strong>Methods: </strong>A quasi-experimental, pre- and post-test intervention design was used to assess the effect of a multiphase intervention on guideline adherence and prophylactic anticonvulsant prescription rates. The 16-week intervention consisted of provider education sessions, provider alerts, documentation templates, and a weekly audit and feedback. Participants included four providers and newly diagnosed seizure-naive brain tumor patients. Measures included guideline adherence rates and AED prescription rates extracted from chart review, and a provider attitude and knowledge survey. Analyses included descriptive statistics, Wilcoxon signed-rank tests, and Chi-square tests.</p><p><strong>Results: </strong>Guideline adherence increased significantly (<i>p</i> < .01) from 4 months before implementation (15.8%) to 1 year before implementation (27.8%) and then to 93.3% after implementation. Provider knowledge showed clinically meaningful decreases in the likelihood to prescribe prophylactic AEDs (-.5 point) and increased understanding of prophylactic AED side effects (+0.5 point), although these were not statistically significant (<i>p</i> = .083). Finally, prophylactic AED prescription rates decreased by 2.2% (<i>p</i> = .119) compared with 4 months and 1 year before implementation (2.6%; <i>p</i> = .072).</p><p><strong>Conclusion: </strong>This project highlights the important role of provider education, provider alerts, a documentation template, and audit and feedback in improving guideline adherence rate. Findings suggest that the combination intervention and weekly audit and feedback strategy can improve guideline adherence to prophylactic anticonvulsant use in seizure-naive newly diagnosed brain tumor patients.</p><p><strong>Implications: </strong>By following prophylactic AED guideline recommendations, clinicians can avoid the potential side effects of anticonvulsant-induced cognitive, behavioral, and psychiatric issues that can impair patients' quality of life.</p>","PeriodicalId":17176,"journal":{"name":"Journal of the Advanced Practitioner in Oncology","volume":"13 8","pages":"775-789"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/98/jadpro-13-775.PMC9881735.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Advanced Practitioner in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6004/jadpro.2022.13.8.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background and purpose: Clinical guidelines suggest that prophylactic antiepileptic drugs (AEDs) should be given to newly diagnosed seizure-naive brain tumor patients for up to 1 week after craniotomy. Yet, data suggest that prophylactic AEDs are used up to 12 months after surgery. A quality improvement project was implemented to improve adherence to evidence-based prophylactic AED guidelines.

Methods: A quasi-experimental, pre- and post-test intervention design was used to assess the effect of a multiphase intervention on guideline adherence and prophylactic anticonvulsant prescription rates. The 16-week intervention consisted of provider education sessions, provider alerts, documentation templates, and a weekly audit and feedback. Participants included four providers and newly diagnosed seizure-naive brain tumor patients. Measures included guideline adherence rates and AED prescription rates extracted from chart review, and a provider attitude and knowledge survey. Analyses included descriptive statistics, Wilcoxon signed-rank tests, and Chi-square tests.

Results: Guideline adherence increased significantly (p < .01) from 4 months before implementation (15.8%) to 1 year before implementation (27.8%) and then to 93.3% after implementation. Provider knowledge showed clinically meaningful decreases in the likelihood to prescribe prophylactic AEDs (-.5 point) and increased understanding of prophylactic AED side effects (+0.5 point), although these were not statistically significant (p = .083). Finally, prophylactic AED prescription rates decreased by 2.2% (p = .119) compared with 4 months and 1 year before implementation (2.6%; p = .072).

Conclusion: This project highlights the important role of provider education, provider alerts, a documentation template, and audit and feedback in improving guideline adherence rate. Findings suggest that the combination intervention and weekly audit and feedback strategy can improve guideline adherence to prophylactic anticonvulsant use in seizure-naive newly diagnosed brain tumor patients.

Implications: By following prophylactic AED guideline recommendations, clinicians can avoid the potential side effects of anticonvulsant-induced cognitive, behavioral, and psychiatric issues that can impair patients' quality of life.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新诊断脑肿瘤患者遵守预防性抗惊厥药指南:一项质量改善研究
背景与目的:临床指南建议,新诊断为癫痫发作的脑肿瘤患者开颅后应给予预防性抗癫痫药物(AEDs)长达1周。然而,数据显示,预防性aed在手术后12个月仍在使用。实施了一项质量改进项目,以提高对循证预防性AED指南的依从性。方法:采用准实验、测试前和测试后干预设计来评估多阶段干预对指南依从性和预防性抗惊厥药物处方率的影响。为期16周的干预包括提供者教育会议、提供者警报、文档模板和每周审计和反馈。参与者包括四名提供者和新诊断的癫痫发作初期脑肿瘤患者。测量包括从图表回顾中提取的指南依从率和AED处方率,以及提供者态度和知识调查。分析包括描述性统计、Wilcoxon符号秩检验和卡方检验。结果:从实施前4个月(15.8%)到实施前1年(27.8%),再到实施后的93.3%,指南依从性显著增加(p < 0.01)。提供者知识显示,开具预防性aed的可能性有临床意义的降低。5分)和对预防性AED副作用的认识增加(+0.5分),尽管这些没有统计学意义(p = 0.083)。最后,与实施前4个月和1年相比,预防性AED处方率下降2.2% (p = 0.119) (2.6%;P = .072)。结论:本项目强调了提供者教育、提供者提醒、文档模板以及审计和反馈在提高指南依从率方面的重要作用。研究结果表明,联合干预和每周审计反馈策略可以提高初次发作的新诊断脑肿瘤患者预防性抗惊厥药使用指南的依从性。意义:通过遵循预防性AED指南建议,临床医生可以避免抗惊厥药物引起的认知、行为和精神问题的潜在副作用,这些副作用可能损害患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast Cancer Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium Beyond Standard Endocrine Therapy: A New Adjuvant Treatment in High-Risk Early Breast Cancer Evaluating the User-Perceived Benefit of a Virtual Lung Cancer Patient Education and Support Community: LVNG With Lung Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1